Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Logo of scirepAboutEditorial BoardFor AuthorsScientific Reports
PMC full text:
Published online 2024 Oct 1. doi: 10.1038/s41598-024-73574-7

Fig. 8

An external file that holds a picture, illustration, etc.
Object name is 41598_2024_73574_Fig8_HTML.jpg

Prognostic performance of ERBB2 expression in subgroups of ccRCC patients. ERBB2 patients were classified into different subgroups according to race, T stage, N stage, M stage, histological grade, and pathological stage. (AC) The Cox regression analysis results show the prognostic performance of ERBB2 expression levels in terms of (A) overall survival, (B) disease-specific survival, and (C) progression-free interval in different subgroups of ccRCC patients. The results are represented by the hazard ratio (HR). The bar represents the 95% confidence interval (CI) of the HR values, and the size of the circle represents the significance of the prognostic performance of ERBB2.

Images in this article

  • Fig. 1
  • Fig. 2
  • Fig. 3
  • Fig. 4
  • Fig. 5
  • Fig. 6
  • Fig. 7
  • Fig. 8
Click on the image to see a larger version.